Geovax Labs, INC DEF 14A proxy statements

GeoVax Labs announces its 2026 Annual Meeting of Stockholders, detailing proposals for director elections, warrant exercise approvals, and auditor ratification.

GeoVax Labs, Inc. is seeking stockholder approval for the issuance of shares related to a September 2025 private placement and a reverse stock split to maintain Nasdaq listing compliance.

GeoVax Labs is holding its annual meeting to elect directors, approve a new stock incentive plan, approve the issuance of shares upon warrant exercise, and ratify the appointment of its accounting firm.

GeoVax Labs is holding a special meeting to seek stockholder approval for the issuance of common stock upon the exercise of warrants related to recent private placements, aiming to secure additional funding and comply with Nasdaq listing rules.

GeoVax Labs is convening its annual stockholder meeting on May 23, 2024, to vote on key proposals including director elections, warrant issuance approval, by-law amendments, and auditor ratification.